Laboratory Medicine ›› 2017, Vol. 32 ›› Issue (9): 831-836.DOI: 10.3969/j.issn.1673-8640.2017.09.019
• Orginal Article • Previous Articles
WANG Chanjuan, ZHANG Jie, QIAO Rui
Received:
2016-11-24
Online:
2017-09-30
Published:
2017-09-30
CLC Number:
WANG Chanjuan, ZHANG Jie, QIAO Rui. Research progress on TMEM16F and related diseases[J]. Laboratory Medicine, 2017, 32(9): 831-836.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2017.09.019
[1] | YANG Y D,CHO H,KOO J Y,et al.TMEM16A confers receptor-activated calcium-dependent chloride conductance[J]. Nature,2008,455(7217):1210-1215. |
[2] | YU K,DURAN C,QU Z,et al.Explaining calcium-dependent gating of anoctamin-1 chloride channels requires a revised topology[J]. Circ Res,2012,110(7):990-999. |
[3] | YANG H,KIM A,DAVID T,et al.TMEM16F forms a Ca2+ -activated cation channel required for lipid scrambling in platelets during blood coagulation[J]. Cell,2012,151(1):111-122. |
[4] | KUNZELMANN K,TIAN Y,MARTINS J R,et al.Anoctamins[J]. Pflugers Arch,2011,462(2):195-208. |
[5] | KUNZELMANN K,SCHREIBER R,KMIT A,et al.Expression and function of epithelial anoctamins[J]. Exp Physiol,2012,97(2):184-192. |
[6] | MALVEZZI M,CHALAT M,JANJUSEVIC R,et al.Ca2+-dependent phospholipid scrambling by a reconstituted TMEM16 ion channel[J]. Nat Commun,2013,4:2367. |
[7] | TIAN Y,SCHREIBER R,KUNZELMANN K.Anoctamins are a family of Ca2+-activated Cl- channels[J]. J Cell Sci,2012,125(Pt 21):4991-4998. |
[8] | KMIT A,VAN KRUCHTEN R,OUSINGSAWAT J,et al.Calcium-activated and apoptotic phospholipid scrambling induced by Ano6 can occur independently of Ano6 ion currents[J]. Cell Death Dis,2013,4:e611. |
[9] | VIITANEN T M,SUKUMARAN P,LÖF C,et al. Functional coupling of TRPC2 cation channels and the calcium-activated anion channels in rat thyroid cells:implications for iodide homeostasis[J]. J Cell Physiol,2013,228(4):814-823. |
[10] | MARTINS J R,FARIA D,KONGSUPHOL P,et al.Anoctamin 6 is an essential component of the outwardly rectifying chloride channel[J]. Proc Natl Acad Sci U S A,2011,108(44):18168-18172. |
[11] | AGUIRRE A,SHOJI K F,SÁEZ J C,et al. FasL-triggered death of Jurkat cells requires caspase 8-induced,ATP-dependent cross-talk between Fas and the purinergic receptor P2X(7)[J]. J Cell Physiol,2013,228(2):485-493. |
[12] | SCUDIERI P,CACI E,VENTURINI A,et al.Ion channel and lipid scramblase activity associated with expression of TMEM16F/ANO6 isoforms[J]. J Physiol,2015,593(17):3829-3848. |
[13] | BEVERS E M,WILLIAMSON P L.Phospholipid scramblase:an update[J]. FEBS Lett ,2010,584(13):2724-2730. |
[14] | HEEMSKERK J W,BEVERS E M,LINDHOUT T.Platelet activation and blood coagulation[J]. Thromb Haemost,2002,88(2):186-193. |
[15] | DALE G L.Coated-platelets:an emerging component of the procoagulant response[J]. J Thromb Haemost,2005,3(10):2185-2192. |
[16] | DASGUPTA S K,ARGAIZ E R,MERCADO J E,et al.Platelet senescence and phosphatidylserine exposure[J]. Transfusion,2010,50(10):2167-2175. |
[17] | FUJII T,SAKATA A,NISHIMURA S,et al.TMEM16F is required for phosphatidylserine exposure and microparticle release in activated mouse platelets[J]. Proc Natl Acad Sci U S A,2015,112(41):12800-12805. |
[18] | KUNZELMANN K,NILIUS B,OWSIANIK G,et al.Molecular functions of anoctamin 6(TMEM16F):a chloride channel,cation channel,or phospholipid scramblase?[J]. Pflugers Arch,2014,466(3):407-414. |
[19] | VAN KRUCHTEN R,MATTHEIJ N J,SAUNDERS C,et al.Both TMEM16F-dependent and TMEM16F-independent pathways contribute to phosphatidylserine exposure in platelet apoptosis and platelet activation[J]. Blood,2013,121(10):1850-1857. |
[20] | WILLIAMSON P,CHRISTIE A,KOHLIN T,et al.Phospholipid scramblase activation pathways in lymphocytes[J]. Biochemistry,2001,40(27):8065-8072. |
[21] | SCHOENWAELDER S M,YUAN Y,JOSEFSSON E C,et al.Two distinct pathways regulate platelet phosphatidylserine exposure and procoagulant function[J]. Blood,2009,114(3):663-666. |
[22] | SEGAWA K,KURATA S,YANAGIHASHI Y,et al.Caspase-mediated cleavage of phospholipid flippase for apoptotic phosphatidylserine exposure[J]. Science,2014,344(6188):1164-1168. |
[23] | YU K,WHITLOCK J M,LEE K,et al.Identification of a lipid scrambling domain in ANO6/TMEM16F[J]. Elife,2015,4:e06901. |
[24] | YANG H,KIM A,DAVID T,et al.TMEM16F forms a Ca2+-activated cation channel required for lipid scrambling in platelets during blood coagulation[J]. Cell,2012,151(1):111-122. |
[25] | MUNNIX I C,HARMSMA M,GIDDINGS J C,et al.Store-mediated calcium entry in the regulation of phosphatidylserine exposure in blood cells from Scott patients[J]. Thromb Haemost,2003,89(4):687-695. |
[26] | SUZUKI J,UMEDA M,SIMS P J,et al.Calcium-dependent phospholipid scrambling by TMEM16F[J]. Nature,2010,468(7325):834-838. |
[27] | MATTHEIJ N J,BRAUN A,VAN KRUCHTEN R,et al.Survival protein anoctamin-6 controls multiple platelet responses including phospholipid scrambling,swelling,and protein cleavage[J]. FASEB J,2016,30(2):727-737. |
[28] | HALLIEZ M,FOUASSIER M,ROBILLARD N,et al.Detection of phosphatidyl serine on activated platelets' surface by flow cytometry in whole blood:a simpler test for the diagnosis of Scott syndrome[J]. Br J Haematol, 2015. [Epub ahead of print] |
[29] | TSUTSUMI S,KAMATA N,VOKES T J,et al.The novel gene encoding a putative transmembrane protein is mutated in gnathodiaphyseal dysplasia(GDD)[J]. Am J Hum Genet,2004,74(6):1255-1261. |
[30] | EHLEN H W,CHINENKOVA M,MOSER M,et al.Inactivation of anoctamin-6/Tmem16f,a regulator of phosphatidylserine scrambling in osteoblasts,leads to decreased mineral deposition in skeletal tissues[J]. J Bone Miner Res,2013,28(2):246-259. |
[31] | DAMEK-POPRAWA M,GOLUB E,OTIS L,et al.Chondrocytes utilize a cholesterol-dependent lipid translocator to externalize phosphatidylserine[J]. Biochemistry,2006,45(10):3325-3336. |
[32] | HOFFMANN E K,LAMBERT I H,PEDERSEN S F.Physiology of cell volume regulation in vertebrates[J]. Physiol Rev,2009,89(1):193-277. |
[33] | VOSS F K,ULLRICH F,MÜNCH J,et al. Identification of LRRC8 heteromers as an essential component of the volume-regulated anion channel VRAC[J]. Science,2014,344(6184):634-638. |
[34] | SIRIANANT L,OUSINGSAWAT J,WANITCHAKOOL P,et al.Cellular volume regulation by anoctamin 6:Ca2+,phospholipaseA2 and osmosensing[J]. Pflugers Arch,2016 ,468(2):335-349. |
[35] | PEDERSEN S,LAMBERT I H,THOROED S M,et al.Hypotonic cell swelling induces translocation of the alpha isoform of cytosolic phospholipase A2 but not the gamma isoform in Ehrlich ascites tumor cells[J]. Eur J Biochem,2000,267(17):5531-5539. |
[36] | FAN C W,CHEN C Y,CHEN K T,et al.Blockade of phospholipid scramblase 1 with its N-terminal domain antibody reduces tumorigenesis of colorectal carcinomas in vitro and in vivo[J]. J Transl Med,2012,10:254. |
[37] | KATO U,INADOME H,YAMAMOTO M,et al.Role for phospholipid flippase complex of ATP8A1 and CDC50A proteins in cell migration[J]. J Biol Chem,2013,288(7):4922-4934. |
[38] | JACOBSEN K S,ZEEBERG K,SAUTER D R,et al.The role of TMEM16A(ANO1)and TMEM16F(ANO6)in cell migration[J]. Pflugers Arch,2013,465(12):1753-1762. |
[39] | KIM H J,JUN I,YOON J S,et al.Selective serotonin reuptake inhibitors facilitate ANO6(TMEM16F)current activation and phosphatidylserine exposure[J]. Pflugers Arch,2015,467(11):2243-2256. |
[1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
[2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
[3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
[4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
[5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
[6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
[7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
[8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
[9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
[10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
[11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
[12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
[13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
[14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
[15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||